MRK logo
MRK
Merck KGaA

Investments And AI Demand Will Drive Future Success Across Life Science, Healthcare, And Electronics

AN
AnalystConsensusTarget
AnalystConsensusTarget
Not Invested
Consensus Narrative from 17 Analysts
Published
24 Nov 24
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
€153.44
30.2% undervalued intrinsic discount
31 Jul
€107.15
Loading
1Y
-34.2%
7D
-5.2%

Author's Valuation

€153.4

30.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates8

Shared on01 May 25
Fair value Decreased 11%

Read more

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Decreased 2.17%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25
Fair value Increased 13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Decreased 11%

Read more

Shared on26 Mar 25
Fair value Decreased 0.81%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Decreased 0.52%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on12 Mar 25
Fair value Increased 11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more